All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
4 warning events since 2017; the latest 2026-09-02.
From the record
IRIDEX Corporation's filings since 2017 show 4 warning events of 2 kinds: a notice about its exchange listing (8-K item 3.01, 3 times, the latest 2026-09-02); a late-report notice (Form NT 10-K or NT 10-Q, the latest 2023-11-14) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+3% a year over 9 filed years; profitable in 0 of 9.
From the record
IRIDEX Corporation's 9 filed years say what it did: revenue went from $42 million in fiscal 2017 to $53 million in fiscal 2026, up 3% a year; it rose in 5 of 8 years; the deepest fall was 16% from fiscal 2019 to fiscal 2021; net income was positive in 0 of 9 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 8.0/10, confidence 35 of 100 (one part).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: IRIDEX Corporation's shareholder treatment is put at 8.0 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the top 20% of 27 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -90%: lost 90¢ per shareholder dollar. Leverage 83%: owes 83¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2026-01-03, IRIDEX Corporation lost about 90 cents for every dollar of shareholders' money, and gross profitability: its products earned about 66 cents per dollar of everything the company owns. Leverage: it owed about 83 cents per dollar of assets, and net share issuance: its share count grew 3.0% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
bottom 45% of 24 in its family; net margin -8.4%.
From the record
IRIDEX Corporation's standing among 24 graded names in its industry family: revenue of $53 million in fiscal 2026 ranks in the top 48% by size; a net margin of -8.4% ranks in the top 35%; revenue growth of -2.6% a year over the last 3 filed years ranks in the bottom 18% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
bottom 47% of 19 in its family for leadership; chief executive since 2024.
From the record
IRIDEX Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Mercer, Patrick (President and CEO, as filed), filing under that title since 2024-11-08, 2 years (bottom 42% of its family); the 3 officers and directors filing in the last fifteen months have been on the record a median of 11 years (top 3%); 10 officer or director changes were reported on Form 8-K since 2023-11-13, against the 3 people in charge now (bottom 2%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they set up to do next?
How much room does it have to grow?
bottom 39% of 23 in its family for room to expand.
From the record
IRIDEX Corporation's room to grow, from the newest filed statements (fiscal 2026): cash of $6 million against no long-term debt tagged leaves 20.7% of its assets as net cash, top 40% of its family; cash from operations less capital spending is -4.3% of revenue (top 41%); a gross margin of 36.5% (bottom 11%); research spending of 7% of revenue (bottom 25%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 25% of 25 in its family for growth drivers.
From the record
IRIDEX Corporation's growth drivers, from the filed years to fiscal 2026: revenue grew -2.6% a year over the last three filed years against 3% over all 9, slowing (bottom 33% of its family); the newest year grew 8.1% (bottom 37%); research spending grew -20% a year (bottom 10%); capital spending grew -20.6% a year (bottom 19%) (its annual reports). IRIDEX Corporation reported 4 product lines in fiscal 2025: Retina at $30 million (57%), Cyclo G Six at $14 million (26%), Product and Service Other at $9 million (16%), and 1 more; 3 of 4 grew against the year before (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
top 30% of 20 in its family for expectations against reality.
From the record
IRIDEX Corporation's newest year against its own record: revenue of $53 million in fiscal 2026 came in 17.1% above the $45 million its prior three years' pace pointed to (top 31% of its family); net income of $4 million against a prior three-year average of $9 million (top 16%); a net margin of -8.4% against -16.7% before (top 42%) (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made